Grant Genetics Companies

Reboot Rx is a nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments.

Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.

Center for Aquaculture Technologies is a research and development company using all modern genetic improvement technologies.

InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.

Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Designing the crops of the next generation.

Tavira Therapeutics develops an advanced platform that enhances AAV (adeno-associated virus) gene delivery.

Acrigen Biosciences is dedicated to making gene editing safe.

Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.

Index is a genetic food system traceability solutions provider specializing in source-of-origin traceability and identity preservation.

Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.

Dovetail uses proximity ligation technology in genomics, providing insights into genomic structures and variations.

We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.

Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.

Altratech Limited designs biosensors and semiconductor chips for DNA testing of food traceability for agri business.

Perlara, PBC is precision drug discovery that leaves no mutation behind.

Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.